The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
27810440 |
30 |
Synthesis and structure activity relationships of glycine amide derivatives as novel Vascular Adhesion Protein-1 inhibitors. |
Astellas Pharma |
24996144 |
20 |
Design, synthesis and structure-activity relationships of novel 4-phenoxyquinoline derivatives containing pyridazinone moiety as potential antitumor agents. |
Key Laboratory Of Structure-Based Drug Design And Discovery (Shenyang Pharmaceutical University) |
23664164 |
40 |
Novel 1H-imidazol-2-amine derivatives as potent and orally active vascular adhesion protein-1 (VAP-1) inhibitors for diabetic macular edema treatment. |
Astellas Pharma |
23540955 |
24 |
Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema: part 2. |
Astellas Pharma |
23337801 |
24 |
Synthesis and SAR study of new thiazole derivatives as vascular adhesion protein-1 (VAP-1) inhibitors for the treatment of diabetic macular edema. |
Astellas Pharma |
20690686 |
52 |
Synthesis, in vitro activity, and three-dimensional quantitative structure-activity relationship of novel hydrazine inhibitors of human vascular adhesion protein-1. |
Fi-40014 University Of Jyvaskyla |
22595173 |
68 |
The discovery and development of selective 3-fluoro-4-aryloxyallylamine inhibitors of the amine oxidase activity of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 (SSAO/VAP-1). |
Pharmaxis |
15689151 |
112 |
Alkylamino derivatives of 4-aminomethylpyridine as inhibitors of copper-containing amine oxidases. |
Universit£ |
21405023 |
8 |
Novel hydrazine molecules as tools to understand the flexibility of vascular adhesion protein-1 ligand-binding site: toward more selective inhibitors. |
University Of Jyva£Skyla£ |
28245905 |
70 |
Synthesis of readily available fluorophenylalanine derivatives and investigation of their biological activity. |
Charles University |
27881238 |
6 |
Rational identification of natural organic compounds to target the intermolecular interaction between Foxm and DNA in colorectal cancer. |
Linyi People'S Hospital |
18578471 |
16 |
Synthesis and pharmacological evaluation of novel gamma-aminobutyric acid type B (GABAB) receptor agonists as gastroesophageal reflux inhibitors. |
Astrazeneca |
16190759 |
60 |
A novel series of non-carboxylic acid, non-hydantoin inhibitors of aldose reductase with potent oral activity in diabetic rat models: 6-(5-chloro-3-methylbenzofuran-2-sulfonyl)-2H-pyridazin-3-one and congeners. |
Pfizer |
28836754 |
31 |
Cell Lysate-Based AlphaLISA Deubiquitinase Assay Platform for Identification of Small Molecule Inhibitors. |
University Of Delaware |